Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 14, 2008; 14(10): 1559-1563
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1559
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1559
Anti-HAV (+)2 | Anti-HAV (-) | P value | |
(n = 133) | (n = 49) | ||
Age (yr) | 31.5 ± 9.6 | 31.8 ± 8.7 | 0.844 |
Sex (M/F) | 62/71 | 26/23 | 0.440 |
Duration of transfusion therapy (y) | 26.5 ± 8.1 | 27.1 ± 9.6 | 0.683 |
Number of transfusions | 989 ± 441 | 772 ± 556 | 0.020 |
Splenectomy | 47 (35.3%) | 25 (51%) | 0.055 |
AST (IU/L)1 | 38.6 ± 24.2 | 58.3 ± 36.1 | 0.001 |
ALT (IU/L) | 49.2 ± 36.2 | 62.5 ± 40.8 | 0.039 |
GGT (IU/L) | 29.6 ± 26.0 | 39.1 ± 27.3 | 0.057 |
Albumin (g/dL) | 4.7 ± 0.45 | 4.47 ± 0.57 | 0.025 |
Globulins (g/dL) | 3.03 ± 0.85 | 3.26 ± 0.79 | 0.122 |
Ferritin (median, ng/mL) | 1515 | 1815 | 0.590 |
Anti-HCV (+) | 61 (45.9%) | 15 (30.6%) | 0.064 |
HCV RNA (+) | 36 (27.1%) | 8 (16.3%) | 0.133 |
- Citation: Siagris D, Kouraklis-Symeonidis A, Konstantinidou I, Christofidou M, Starakis I, Lekkou A, Papadimitriou C, Blikas A, Zoumbos N, Labropoulou-Karatza C. Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia. World J Gastroenterol 2008; 14(10): 1559-1563
- URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1559.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1559